Dr. Ramon Quesada, MD

Dr. Quesada practices at Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. Quesada's NPI, 1134125347, was assigned on June 22, 2005. Dr. Quesada graduated from Universidad de El Salvador Faculty of Medicine in 1980. Dr. Quesada holds Florida license ME44807.

Dr. Quesada's primary practice is Baptist Health Baptist Hospital, at 8900 N Kendall Dr, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 596-1960.

Dr. Quesada's primary practice is Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. Dr. Quesada is also affiliated with South Miami Hospital. The medical group on file is Baptist Health Medical Group. Dmand AI also links Dr. Quesada to 3 more hospitals, 4 group practices and clinics, 3 medical groups and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Quesada practices, 10 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Quesada's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Quesada is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Quesada's licenses on file in 2 states: Florida and Texas.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Quesada treats.

CMS data shows 1,220 Medicare services from Dr. Quesada across 16 procedure codes in 2024, for 605 Medicare patients. Medicare paid $126,920 for them.

CMS counts 605 Medicare patients who saw Dr. Quesada in 2024. The largest group is 75 to 84, with 258 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Quesada's median patient age at 75, with 42% women.

In 2024, Dr. Quesada wrote 2,129 Medicare Part D claims for 324 patients. 78% of them were for generic drugs. CMS names the drug for 1,885 of them, across 33 drugs with 11 or more claims each, at $470,052 in total drug cost. In 2023, CMS named 1,969 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Quesada for performance year 2024, reported through an alternative payment model (APM). Dr. Quesada accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Quesada as offering telehealth. CMS counts 18 procedures of coronary angioplasty and stenting by Dr. Quesada, more than 46% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Quesada, published from 2022 to 2025. Dr. Quesada's most frequent co-authors are Elliott J. Elias, MD, MPH, Surendra B. Avula, MD and Wayne B. Batchelor, MD.

CMS Open Payments shows 676 general payments to Dr. Quesada from 50 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 34% of the total. Abbott Laboratories paid the most, $109,840. It also lists 4 research payments totaling $40,078 from 2019 to 2024.

Dmand AI lists 5 awards for Dr. Quesada, most recently CMS Stage 1 EHR in 2013.

Dr. Quesada graduated from Universidad de El Salvador Faculty of Medicine in 1980. Dr. Quesada is a member of ACC, ACP and AHA.

Dr. Quesada is in network with 10 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.